Risk and Severity of COVID-19 and ABO Blood Group in Transcatheter Aortic Valve Patients.

ABSTRACT: While cardiovascular disease has been associated with an increased risk of coronavirus disease 2019 (COVID-19), no studies have described its clinical course in patients with aortic stenosis who had undergone transcatheter aortic valve replacement (TAVR). Numerous observational studies have reported an association between the A blood group and an increased susceptibility to SARS-CoV-2 infection. Our objective was to investigate the frequency and clinical course of COVID-19 in a large sample of patients who had undergone TAVR and to determine the associations of the ABO blood group with disease occurrence and outcomes. Patients who had undergone TAVR between 2010 and 2019 were included in this study and followed-up through the recent COVID-19 outbreak. The occurrence and severity (hospitali

SUBMITTER: Kibler M 

PROVIDER: S-EPMC7700222 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature